332 related articles for article (PubMed ID: 19273909)
1. Ca2+/calmodulin-dependent kinase II triggers cell membrane injury by inducing complement factor B gene expression in the mouse heart.
Singh MV; Kapoun A; Higgins L; Kutschke W; Thurman JM; Zhang R; Singh M; Yang J; Guan X; Lowe JS; Weiss RM; Zimmermann K; Yull FE; Blackwell TS; Mohler PJ; Anderson ME
J Clin Invest; 2009 Apr; 119(4):986-96. PubMed ID: 19273909
[TBL] [Abstract][Full Text] [Related]
2. MyD88 mediated inflammatory signaling leads to CaMKII oxidation, cardiac hypertrophy and death after myocardial infarction.
Singh MV; Swaminathan PD; Luczak ED; Kutschke W; Weiss RM; Anderson ME
J Mol Cell Cardiol; 2012 May; 52(5):1135-44. PubMed ID: 22326848
[TBL] [Abstract][Full Text] [Related]
3. Ca2+/Calmodulin-dependent protein kinase II δ mediates myocardial ischemia/reperfusion injury through nuclear factor-κB.
Ling H; Gray CB; Zambon AC; Grimm M; Gu Y; Dalton N; Purcell NH; Peterson K; Brown JH
Circ Res; 2013 Mar; 112(6):935-44. PubMed ID: 23388157
[TBL] [Abstract][Full Text] [Related]
4. Calmodulin kinase II inhibition protects against myocardial cell apoptosis in vivo.
Yang Y; Zhu WZ; Joiner ML; Zhang R; Oddis CV; Hou Y; Yang J; Price EE; Gleaves L; Eren M; Ni G; Vaughan DE; Xiao RP; Anderson ME
Am J Physiol Heart Circ Physiol; 2006 Dec; 291(6):H3065-75. PubMed ID: 16861697
[TBL] [Abstract][Full Text] [Related]
5. Blockade of L-type Ca
Ikeda S; Matsushima S; Okabe K; Ikeda M; Ishikita A; Tadokoro T; Enzan N; Yamamoto T; Sada M; Deguchi H; Morimoto S; Ide T; Tsutsui H
Sci Rep; 2019 Jul; 9(1):9850. PubMed ID: 31285514
[TBL] [Abstract][Full Text] [Related]
6. Ca
Baier MJ; Klatt S; Hammer KP; Maier LS; Rokita AG
J Mol Cell Cardiol; 2020 Jan; 138():212-221. PubMed ID: 31836540
[TBL] [Abstract][Full Text] [Related]
7. Tilianin Protects against Ischemia/Reperfusion-Induced Myocardial Injury through the Inhibition of the Ca
Jiang H; Xing J; Fang J; Wang L; Wang Y; Zeng L; Li Z; Liu R
Biomed Res Int; 2020; 2020():5939715. PubMed ID: 33102583
[TBL] [Abstract][Full Text] [Related]
8. Deficiency of Capn4 gene inhibits nuclear factor-κB (NF-κB) protein signaling/inflammation and reduces remodeling after myocardial infarction.
Ma J; Wei M; Wang Q; Li J; Wang H; Liu W; Lacefield JC; Greer PA; Karmazyn M; Fan GC; Peng T
J Biol Chem; 2012 Aug; 287(33):27480-9. PubMed ID: 22753411
[TBL] [Abstract][Full Text] [Related]
9. RhoE Fine-Tunes Inflammatory Response in Myocardial Infarction.
Dai Y; Song J; Li W; Yang T; Yue X; Lin X; Yang X; Luo W; Guo J; Wang X; Lai S; Andrade KC; Chang J
Circulation; 2019 Feb; 139(9):1185-1198. PubMed ID: 30586715
[TBL] [Abstract][Full Text] [Related]
10. Ablation of phospholamban rescues reperfusion arrhythmias but exacerbates myocardium infarction in hearts with Ca2+/calmodulin kinase II constitutive phosphorylation of ryanodine receptors.
Valverde CA; Mazzocchi G; Di Carlo MN; Ciocci Pardo A; Salas N; Ragone MI; Felice JI; Cely-Ortiz A; Consolini AE; Portiansky E; Mosca S; Kranias EG; Wehrens XHT; Mattiazzi A
Cardiovasc Res; 2019 Mar; 115(3):556-569. PubMed ID: 30169578
[TBL] [Abstract][Full Text] [Related]
11. Phosphoproteomics study based on in vivo inhibition reveals sites of calmodulin-dependent protein kinase II regulation in the heart.
Scholten A; Preisinger C; Corradini E; Bourgonje VJ; Hennrich ML; van Veen TA; Swaminathan PD; Joiner ML; Vos MA; Anderson ME; Heck AJ
J Am Heart Assoc; 2013 Aug; 2(4):e000318. PubMed ID: 23926118
[TBL] [Abstract][Full Text] [Related]
12. Inhibition of CaMKII does not attenuate cardiac hypertrophy in mice with dysfunctional ryanodine receptor.
Chakraborty A; Pasek DA; Huang TQ; Gomez AC; Yamaguchi N; Anderson ME; Meissner G
PLoS One; 2014; 9(8):e104338. PubMed ID: 25093823
[TBL] [Abstract][Full Text] [Related]
13. Over-expression of Kv4.3 gene reverses cardiac remodeling and transient-outward K
Tao B; Liu Z; Wei F; Fan S; Cui S; Xia H; Xu L
Biomed Pharmacother; 2020 Dec; 132():110896. PubMed ID: 33254430
[TBL] [Abstract][Full Text] [Related]
14. Silencing of ATP2B1-AS1 contributes to protection against myocardial infarction in mouse via blocking NFKBIA-mediated NF-κB signalling pathway.
Song KY; Zhang XZ; Li F; Ji QR
J Cell Mol Med; 2020 Apr; 24(8):4466-4479. PubMed ID: 32155320
[TBL] [Abstract][Full Text] [Related]
15. Pathological implication of CaMKII in NF-κB pathway and SASP during cardiomyocytes senescence.
Li T; Meng Y; Ding P; Wang H; Liu J; Xia C; Chen Y; Li J
Mech Ageing Dev; 2023 Jan; 209():111758. PubMed ID: 36462537
[TBL] [Abstract][Full Text] [Related]
16. Ca
Meng Y; Ding P; Wang H; Yang X; Wang Z; Nie D; Liu J; Huang Y; Su G; Hu J; Su Y; Du X; Dong N; Jia H; Zhang H; Zhang J; Li J
Biochim Biophys Acta Mol Cell Biol Lipids; 2022 Jun; 1867(6):159120. PubMed ID: 35231606
[TBL] [Abstract][Full Text] [Related]
17. The CaMKII phosphorylation site Thr1604 in the Ca
Li J; Wang S; Zhang J; Liu Y; Zheng X; Ding F; Sun X; Zhao M; Hao L
Channels (Austin); 2020 Dec; 14(1):151-162. PubMed ID: 32290730
[TBL] [Abstract][Full Text] [Related]
18. Dynamic alterations in the CaV1.2/CaM/CaMKII signaling pathway in the left ventricular myocardium of ischemic rat hearts.
Zhao Y; Hu HY; Sun DR; Feng R; Sun XF; Guo F; Hao LY
DNA Cell Biol; 2014 May; 33(5):282-90. PubMed ID: 24548334
[TBL] [Abstract][Full Text] [Related]
19. CaMKII effects on inotropic but not lusitropic force frequency responses require phospholamban.
Wu Y; Luczak ED; Lee EJ; Hidalgo C; Yang J; Gao Z; Li J; Wehrens XH; Granzier H; Anderson ME
J Mol Cell Cardiol; 2012 Sep; 53(3):429-36. PubMed ID: 22796260
[TBL] [Abstract][Full Text] [Related]
20. Targeting CaMKII-δ9 Ameliorates Cardiac Ischemia/Reperfusion Injury by Inhibiting Myocardial Inflammation.
Yao Y; Li F; Zhang M; Jin L; Xie P; Liu D; Zhang J; Hu X; Lv F; Shang H; Zheng W; Sun X; Duanmu J; Wu F; Lan F; Xiao RP; Zhang Y
Circ Res; 2022 Mar; 130(6):887-903. PubMed ID: 35152717
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
